TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target

por Yu, Jiao-jiao, Zhou, Dan-dan, Yang, Xiao-xiao, Cui, Bing, Tan, Feng-wei, Wang, Junjian, Li, Ke, Shang, Shuang, Zhang, Cheng, Lv, Xiao-xi, Zhang, Xiao-wei, Liu, Shan-shan, Yu, Jin-mei, Wang, Feng, Huang, Bo, Hua, Fang, Hu, Zhuo-Wei
Publicado 2020

TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation

por Li, Ke, Wang, Feng, Yang, Zhao-na, Zhang, Ting-ting, Yuan, Yu-fen, Zhao, Chen-xi, Yeerjiang, Zaiwuli, Cui, Bing, Hua, Fang, Lv, Xiao-xi, Zhang, Xiao-wei, Yu, Jiao-jiao, Liu, Shan-shan, Yu, Jin-mei, Shang, Shuang, Xiao, Yang, Hu, Zhuo-wei
Publicado 2020

TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription

por Yu, Jin-mei, Sun, Wei, Wang, Zhen-he, Liang, Xiao, Hua, Fang, Li, Ke, Lv, Xiao-xi, Zhang, Xiao-wei, Liu, Yu-ying, Yu, Jiao-jiao, Liu, Shan-shan, Shang, Shuang, Wang, Feng, Yang, Zhao-na, Zhao, Chen-xi, Hou, Xue-ying, Li, Ping-ping, Huang, Bo, Cui, Bing, Hu, Zhuo-Wei
Publicado 2019

Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy

por Zhou, Ji-Chao, Jin, Cai-Cai, Wei, Xiao-Li, Xu, Rui-Bing, Wang, Ruo-Yu, Zhang, Zhi-Meng, Tang, Bo, Yu, Jin-Mei, Yu, Jiao-Jiao, Shang, Shuang, Lv, Xiao-Xi, Hua, Fang, Li, Ping-Ping, Hu, Zhuo-Wei, Shen, Yong-Mei, Wang, Feng-Peng, Ma, Xiu-Ying, Cui, Bing, Geng, Fu-Neng, Zhang, Xiao-Wei
Publicado 2023